Menu

Jeremy Berg Named Editor of Science Journals

The former National Institute of General Medical Sciences director replaces outgoing editor and National Academy of Sciences president-elect Marcia McNutt.

May 25, 2016
Tracy Vence

Jeremy Berg (left), Marcia McNuttAAAS, JOSHUA FRANZOS; WIKIMEDIA, USGS

Jeremy Berg will become editor in chief of Science and related journals beginning July 1, the American Association for the Advancement of Science (AAAS) announced today (May 25). Berg, a former director of the National Institute of General Medical Sciences and current associate senior vice chancellor for Science Strategy and Planning in the Health Sciences at the University of Pittsburgh in Pennsylvania, is replacing the outgoing editor of the Science journals, Marcia McNutt. McNutt was nominated president of the National Academy of Sciences last year, and begins her term on July 1.

Berg’s “broad scientific perspective and passionate advocacy for basic research, combined with his interest in scientific policy, makes him a superb spokesperson for the scientific community,” search committee chair and past AAAS president Gerald Fink said in the statement.

“Jeremy Berg will bring exceptional scientific, technical, and administrative experience and insights to the position of editor-in-chief, and I am confident that he will help us to lift our journal’s standards to an even higher level,” AAAS Chief Executive Officer, Science journals publisher, and former US Representative (D-NJ) Rush Holt said in the statement. “We are grateful to Marcia McNutt for her exemplary service, and particularly her efforts to raise the bar of data reproducibility.”

January 2019

Cannabis on Board

Research suggests ill effects of cannabinoids in the womb

Marketplace

Sponsored Product Updates

WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
WIN a VIAFLO 96/384 to supercharge your microplate pipetting!
INTEGRA Biosciences is offering labs the chance to win a VIAFLO 96/384 pipette. Designed to simplify plate replication, plate reformatting or reservoir-to-plate transfers, the VIAFLO 96/384 allows labs without the space or budget for an expensive pipetting robot to increase the speed and throughput of routine tasks.
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX® digital PCR technology to be acquired by QIAGEN
FORMULATRIX has announced that their digital PCR assets, including the CONSTELLATION® series of instruments, is being acquired by QIAGEN N.V. (NYSE: QGEN, Frankfurt Stock Exchange: QIA) for up to $260 million ($125 million upfront payment and $135 million of milestones).  QIAGEN has announced plans for a global launch in 2020 of a new series of digital PCR platforms that utilize the advanced dPCR technology developed by FORMULATRIX combined with QIAGEN’s expertise in assay development and automation.
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
Application of CRISPR/Cas to the Generation of Genetically Engineered Mice
With this application note from Taconic, learn about the power that the CRISPR/Cas system has to revolutionize the field of custom mouse model generation!
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
Translational Models of Obesity, Dysmetabolism, Diabetes, and Complications
This webinar, from Crown Bioscience, presents a unique continuum of translational dysmetabolic platforms that more closely mimic human disease. Learn about using next-generation rodent and spontaneously diabetic non-human primate models to accurately model human-relevant disease progression and complications related to obesity and diabetes here!